Instruction for use: Ungapiven

Dosage form: ointment for external use

Active substance: Bee Venom

ATX

M02AX10 Other drugs

Pharmacological group:

Local irritants

The nosological classification (ICD-10)

G54.1 Lesions of the lumbosacral plexus: Lumbosacral radiculitis; Neuralgia of radicular origin; Pathology of the spine; Radiculitis of the lumbosacral; Radiculoneuritis

M00-M25 Arthropathy

M15-M19 Osteoarthritis

M42 Osteochondrosis of the spine: Pain in osteochondrosis of the spine; Cervical osteochondrosis; Radicular syndrome with osteochondrosis; Intervertebral osteochondrosis; Osteochondrosis; Osteochondrosis with radicular syndrome; Osteocondritis of the spine

M54.3 Sciatica: Ischialgia; Neuralgia of the sciatic nerve; Sciatic neuritis

M54.4 Lumbago with sciatica: Pain in the lumbosacral spine; Lumbago; Sciatica; Lumbar syndrome

M60 Myositis: Myositis; Fibrositis; Fibromyositis; Inflammatory disease of soft tissues

M79.1 Myalgia: Myofascial pain syndromes; Pain syndrome in musculo-articular diseases; Pain syndrome in chronic inflammatory diseases of the musculoskeletal system; Pain in the muscles; Tenderness of muscles; Muscle soreness in severe physical exertion; Painful conditions of the musculoskeletal system; Pain in the musculoskeletal system; Pain in the muscles; Pain at rest; Muscle aches; Muscle pain; Musculoskeletal pain; Myalgia; Muscle pain; Muscle pain at rest; Muscle pain; Muscular pain of non-rheumatic origin; Muscle pain of rheumatic origin; Acute muscle pain; Rheumatic pain; Rheumatic pains; Myofascial syndrome; Fibromyalgia

Composition and release form

1 package ointment contains bee venom 0.018 g, polyethylene oxide 1500 13.5 g and polyethylene oxide 400 to 30 g; in aluminum tubes of 30 g.

Pharmachologic effect

Mode of action - anti-inflammatory, analgesic.

Indications of the drug Ungapiven

Arthritis, arthrosis, osteochondrosis, radiculitis with radicular syndrome, myalgia, myositis, lumbago.

Contraindications

Hypersensitivity, kidney, liver and pancreas diseases, neoplasms, tuberculosis, severe infections, including acute purulent, sepsis, hematopoietic diseases, decompensated circulatory insufficiency, mental illnesses, cachexia, diabetes mellitus, adrenal cortex lesions, pregnancy.

Side effects

Allergic reactions: local (hyperemia, fever and swelling of the skin at the site of application) and general (malaise, chills, headache, nausea, vomiting, fever).

Dosing and Administration

Outer (before use, place the application washed with warm water). Apply a thin layer on the wet surface of the body, rubbing is carried out for 3-5 minutes 1-3 times a day. The course of treatment is 1-4 weeks.

Precautionary measures

Avoid contact with eyes and mucous membranes. It should be borne in mind that women during menstruation and the elderly are hypersensitive to the drug.

Conditions for storing the drug Ungapiven

In a dry, cool place protected from light.

Keep out of the reach of children.

Shelf life of the drug Ungapiven

4 years.

Do not use after the expiry date printed on the package.